MoneyWorks4Me

The Sales for the quarter ended December 2022 of Rs. 560.10 million declined by -36.49% from Rs. 881.88 millions.The Company to register a -54.50%  fall in the net profit for the quarter ended December 2022.A decline of 155.25 millions was observed in the OP in the quarter ended December 2022 from 253.79 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 560.10 881.88 -36.49 1821.92 3920.91 -53.53 4561.32 2615.03 74.43
Other Income 3.52 8.38 -58.00 14.81 19.10 -22.46 35.12 15.88 121.16
PBIDT 155.25 253.79 -38.83 502.51 1574.08 -68.08 1752.36 308.47 468.08
Interest 19.50 5.01 289.22 43.52 18.91 130.14 29.17 26.12 11.68
PBDT 135.75 248.78 -45.43 458.99 1555.17 -70.49 1723.19 282.35 510.30
Depreciation 35.44 31.90 11.10 105.02 78.96 33.00 106.44 64.36 65.38
PBT 100.31 216.88 -53.75 353.97 1476.21 -76.02 1616.75 217.99 641.66
TAX 28.04 58.03 -51.68 85.72 377.25 -77.28 416.29 63.84 552.08
Deferred Tax 2.79 0.03 9200.00 -0.30 2.26 -113.27 2.75 1.62 69.75
PAT 72.27 158.85 -54.50 268.25 1098.96 -75.59 1200.46 154.15 678.76
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 27.72 28.78 -3.68 27.58 40.15 -31.30 38.42 11.80 225.68
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..